Evidence map›Paper›PMID 40542418›Full record

ArticleGenome biology2025

Comparison of spatial transcriptomics technologies using tumor cryosections.

Anne Rademacher, Alik Huseynov, Michele Bortolomeazzi, Sina Jasmin Wille, Sabrina Schumacher, Pooja Sant, Denise Keitel, Konstantin Okonechnikov, David R Ghasemi, Kristian W Pajtler and 2 more

Abstract readComparative Study
In one paragraph

Article in Genome biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Spatial Multiomics Reveal Insights Into ADC Efficacy.European journal of immunology · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anne Rademacher *Division of Chromatin Networks, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Alik Huseynov *German Cancer Research Center (DKFZ), Single Cell Open Lab, Heidelberg, Germany.
Michele Bortolomeazzi *German Cancer Research Center (DKFZ), Single Cell Open Lab, Heidelberg, Germany.
Sina Jasmin WilleDivision of Chromatin Networks, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Sabrina SchumacherDivision of Chromatin Networks, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pooja SantGerman Cancer Research Center (DKFZ), Single Cell Open Lab, Heidelberg, Germany.
Denise KeitelGerman Cancer Research Center (DKFZ), Single Cell Open Lab, Heidelberg, Germany.
Konstantin OkonechnikovHopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
David R GhasemiHopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Kristian W PajtlerHopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Jan-Philipp MallmCenter for Quantitative Analysis of Molecular and Cellular Biosystems (BioQuant), Heidelberg University, Heidelberg, Germany. j.mallm@dkfz.de.
Karsten RippeDivision of Chromatin Networks, German Cancer Research Center (DKFZ), Heidelberg, Germany. karsten.rippe@dkfz.de.

Funding

Deutsche Forschungsgemeinschaft (DFG) 35/1314-1Deutsche Forschungsgemeinschaft (DFG) NFDI 46/1 501864659Deutsche Krebshilfe (German Cancer Aid) Mildred Scheel Doctoral FellowshipGerman Federal Ministry of Education and Research (BMBF) SATURN3 (01KD2206B)Health + Life Science Alliance Heidelberg Mannheim MULTI-SPACEStudienstiftung des Deutschen Volkes (German Academic Scholarship Foundation) Scholarship
6 · The paper itself

Abstract

backgroundSpatial transcriptomics technologies are revolutionizing our understanding of intra-tumor heterogeneity and the tumor microenvironment by revealing single-cell molecular profiles within their spatial tissue context. The rapid development of spatial transcriptomics methods, each with unique characteristics, makes it challenging to select the most suitable technology for specific research objectives. Here, we compare four imaging-based approaches-RNAscope HiPlex, Molecular Cartography, Merscope, and Xenium-alongside Visium, a sequencing-based method. These technologies were employed to study cryosections of medulloblastoma with extensive nodularity (MBEN), a tumor chosen for its distinct microanatomical features.

resultsOur analysis reveals that automated imaging-based spatial transcriptomics methods are well-suited to delineate the intricate MBEN microanatomy and capture cell-type-specific transcriptome profiles. We devise approaches to compare the sensitivity and specificity of different methods, along with their unique attributes, to guide method selection based on the research objective. Furthermore, we demonstrate how reimaging slides after the spatial transcriptomics analysis can significantly improve cell segmentation accuracy and integrate additional transcript and protein readouts, expanding the analytical possibilities and depth of insight.

conclusionsThis study underscores important distinctions between spatial transcriptomics technologies and offers a framework for evaluating their performance. Our findings support informed decisions regarding methods and outline strategies to improve the resolution and scope of spatial transcriptomic analyses, ultimately advancing spatial transcriptomics applications in solid tumor research.

Indexed as

Gene Expression ProfilingMedulloblastomaTranscriptomeHumansTumor MicroenvironmentMedulloblastomaMERFISHMerscopeMolecular CartographyRNAscopeSpatial transcriptomicsVisiumXenium

Identifiers

PMID40542418
PMCPMC12180266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.